{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Echo Wang, Anirban Sen", "title": "SoftBank's Arm IPO six times oversubscribed, sources say - Reuters", "description": "Arm Holdings Plc, the chip designer owned by SoftBank Group Corp <a href=\"https://www.reuters.com/markets/companies/9984.T\" target=\"_blank\">(9984.T)</a> that is seeking roughly $5 billion in its stock market debut, has seen investor demand that is six times t\u2026", "url": "https://www.reuters.com/markets/deals/softbanks-arm-ipo-currently-six-times-oversubscribed-source-2023-09-08/", "urlToImage": "https://www.reuters.com/resizer/cM8oLV32cdH-XdjMZXePi1XzNX0=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/JJ7FPSFWL5NN3MMUR4PDTUIX7A.jpg", "publishedAt": "2023-09-08T18:41:00Z", "content": "NEW YORK, Sept 8 (Reuters) - Arm Holdings Plc, the chip designer owned by SoftBank Group Corp (9984.T) that is seeking roughly $5 billion in its stock market debut, has seen investor demand that is s\u2026 [+3525 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters", "title": "Lilly's diabetes drug gains backing of UK watchdog -Bloomberg News - Reuters", "description": "Eli Lilly's <a href=\"https://www.reuters.com/markets/companies/LLY.N\" target=\"_blank\">(LLY.N)</a> diabetes drug Mounjaro has gained the backing of Britain's healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly \u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-diabetes-drug-gains-backing-uk-watchdog-bloomberg-news-2023-09-08/", "urlToImage": "https://www.reuters.com/resizer/1ZmgZD1C5NptBvvfCEsA5an61Nk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/FAQTJ67KUNKL3H6NZ4DIJMOMOI.jpg", "publishedAt": "2023-09-08T01:58:00Z", "content": "Sept 8 (Reuters) - Eli Lilly's (LLY.N) diabetes drug Mounjaro has gained the backing of Britain's healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly\u2026 [+1477 chars]"}]}